This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Neunteufl, T. Articles by Weidinger, F. Search for Related Content PubMed PubMed Citation Articles by Neunteufl, T. Articles by Weidinger, F.

Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men

^a Department of Cardiology, University of Vienna, Vienna, Austria
^b Department of Vascular Medicine, University of Vienna, Vienna, Austria

View larger version (21K): [in a new window]   Figure 1 Flow-mediated vasodilation (FMD) values of seven patients with hypercholesterolemia at baseline (BL I, II) after combined lipid-lowering and antioxidant therapy (Comb I, II) and after single lipid-lowering therapy (Statin).

View larger version (19K): [in a new window]   Figure 2 Nitroglycerin-induced dilation (NMD) values of seven patients with hypercholesterolemia at baseline (BL I, II) after combined lipid-lowering and antioxidant therapy (Comb I, II) and after single lipid-lowering therapy (Statin).

View larger version (15K): [in a new window]   Figure 3 Mean values of flow-mediated vasodilation (FMD), plasma cholesterol, LDL-cholesterol and alpha-tocopherol/LDL at baseline (BL I, II) after combined lipid-lowering and antioxidant therapy (Comb I, II) and after single lipid-lowering therapy (Statin).